InvestorsHub Logo
Followers 41
Posts 2918
Boards Moderated 0
Alias Born 02/08/2014

Re: None

Thursday, 09/28/2023 11:07:14 AM

Thursday, September 28, 2023 11:07:14 AM

Post# of 408076
Carter is busy right now working on changing our fiscal year. That means we won't get to see the actual Prasco Adderall ER sales until April.

And by the way, the next CFO, the very first mandate for him or her, is going to be change this fiscal year crap from March to a normal year, because that is really annoying.



But it sounds like we will get a PR once they get some orders (which should come before or just after Jan 1) we will get some idea of the value of the deal.

The deal with Burel with Prasco is excellent. It'll materialize and go into effect January 1st for you who do not know. Prasco/Burel are the sales force for the authorized generic and they asked us if we would supply them instead of the authorized generic as of January 1, 2024, and we said, yes.
Once that materialize and see the amount of sales that becomes a material event and we'll discuss it more. But I am estatic about the contract and about Prasco and Burel doing this on their own label, because that helps us also in other financial points in that there are no charge backs and rebates and very complicated financials. This is an easier transaction and it's always nice to protect the Company by having multiple sources of income and not consuming all the working capital into charge backs and rebates.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News